Hb A1cin Pregnancy
Ibrahim A Ali * and Omer A Musa
Department of Physiology, The National Ribat University, Sudan
Submission:September 09, 2018 ; Published: October 15, 2018 ;
*Corresponding author: Ibrahim A Ali, Department of Physiology, Faculty of Medicine, The National Ribat University, Sudan, Email:Hemamedicine@gmail.com
How to cite this article: Ibrahim A A, Omer A M. Hb A1c in Pregnancy. J Gynecol Women’s Health. 2018: 12(2): 555835. DOI: 10.19080/JGWH.2018.12.555835
Introduction and Historical Background of Hb A1c
Hb A1c, is a glycated haemoglobin formed by the glycosylation of haemoglobin. The term ‘glycosylated’ was used initially, but it has been pointed out that this term strictly refers to glycosides. Therefore, the Joint Commission on Biochemical Nomenclature has proposed that the term ‘glycation’ is appropriate for any reaction that links a sugar to a protein, or in the particular case of a reaction with haemoglobin, the term ‘glycated haemoglobin’ [1]. Its value represents the glycaemic status of a person over the last two to three months [2].
According to the American Diabetes Association (ADA) Guidelines 2007, the value of Hb A1c should be kept below 7% in all diabetics and according to the same guidelines, Hb A1c is now referred to as A1c [3]. Hemoglobin A1c was first separated from other forms of hemoglobin by Huisman and Meyering in 1958 using a chromatographic column [4].
In 1969 Glycated haemoglobin (Hb A1c) was initially identified as an “unusual” haemoglobin in diabetic patients by Samuel Rahbar, then he noticed a significant increase in the level of HbA1c in diabetes [5]. Another cross sectional study conducted later by Rahbar et al. at Tehran University found a similar abnormality in 57 diabetic patients [6].
After that discovery, numerous small studies were conducted correlating the HbA1c level to the blood glucose level resulting in the idea that HbA1c could be used as a positive objective factor to measure the glycaemic control. In a larger study of diabetic patients, Trivelli et al found a two-fold increase of Hb A1c over values observed in non-diabetic subjects [7].
Thus, by the mid 1970s, it was clear that HbA1c is elevated in humans with diabetes mellitus, although the mechanism of this abnormality was not understood. In 1975, Bunn et al. [8] described the reactions that lead to formation of HbA1c so the nature of the chemical reaction had been explained. Glycation, is a spontaneous non-enzymatic reaction in which glucose binds covalently with haemoglobin at amino terminal of the globin chain. In 1976 Anthony Cerami proposed the idea to use HbA1C level for monitoring the degree of control of glucose metabolism in diabetic patients, then described Hb A1c as a useful mean for monitoring the glycaemic control in diabetic patients [9]. Hb A1c was introduced into clinical use in the 1980s and subsequently has become an important test in Clinical practice [10].
Hb A1c and Gender
Faerch et al. [11] and Gulliford et al. [12] both found somewhat higher levels of HbA1c in men compared to women [11,12], but other studies found no sex-related differences in Hb A1c [13,14]. In women, Hb A1c levels rose particularly at the age of menopause but the use of oral contraceptives or oestrogens made no difference [15].
In Khartoum state at 2016 Ali et al. [16] performed a Cross-sectional study on 20 non-diabetic adult males of ages between 35-45 years and found a mean Hb A1c of 3.8 % 1.17 with a range of ( 1.2%-5.4 %). Another cross-sectional study also done in Khartoum state at 2016 by Fadul et al. [17] on 20 non-diabetic adult females, their ages was between 35-45 years and found a mean Hb A1c of 3.43 % 1.17 with a range of ( 1.4-5.3%).
Hb A1c and pregnancy
Diabetes in pregnant women is associated with increased occurrence of both fetal and maternal adverse events, including macrosomia, congenital malformations, spontaneous abortion, perinatal mortality, and preeclampsia [18,19]. The close relationship between the development of such complications and maternal hyperglycemia has been widely documented. Several studies have also shown that strict glycemic control before conception and throughout the gestational period can improve the outcome of pregnancies in women with diabetes, reducing the risk of complications to a rate similar to that found in uncomplicated pregnancies [20-22].
As a consequence, the improvement of glycemic control is considered a major topic in the management of pregnancies complicated by diabetes. Nielsen et al. [23] performed a case control study in Copenhagen, Denmark at 2004 , on 100 healthy pregnant women without previous gestational diabetes (early pregnancy group). A late pregnancy group of 98 healthy pregnant women in week 33 (range 28-37) , the non pregnant control group consisted of 145 healthy women aged 30 years. The result showed that HbA1c was significantly decreased early in pregnancy and further decreased in late pregnancy compared with age-matched nonpregnant women. The normal range of HbA1c was 4.7-6.3% in nonpregnant women, 4.5-5.7% in early pregnancy, and 4.4-5.6% in late pregnancy.
Mosca et al. [24] conducted a study in Italy and found the HbA1C reference intervals were 4.0%-5.5% for pregnant nondiabetic women and 4.8%-6.2% for nonpregnant controls. The HbA1C results for nondiabetic pregnant women at different gestational periods were 3.8-5.5% at 15-24 weeks, 4.0-5.5% at 25-27 weeks, and a small but significant increase in HbA1C values at 28-36 weeks, 4.4-5.5%.
O’Connor et al. [25] stated that because the pregnant women are younger and the fasting blood glucose increases over age, the relatively older, healthy non-pregnant women may have high Hb A1c . Also, they reported that the lifespan of red blood cells reduces in pregnant women (including those with diabetes mellitus), resulting in reduction in HbA1c.
O’Kane et al. [26] proposed that the reference range of HbA1C is 4.1-5.9% in pregnant women without DM, and in the first, second and third trimesters, the level of HbA1C was 5.1%, 4.9% and 5.0%, respectively. Shobha et al. [27] performed a study to measure glycosylated hemoglobin values in nondiabetic pregnant women in the third trimester and found HbA1C values in the third trimester of pregnancy ranged from 4.5% to 6%.
In 2011 Ismail et al. [28] performed A descriptive, cross sectional study in Yastabsheron obstetric hospital at Khartoum state capital of Sudan to estimate the concentration of Hb A1c in apparently healthy 90 pregnant Sudanese women as well as in apparently healthy 30 non pregnant Sudanese women, which showed that, the mean concentration of the Hb A1c in pregnant group was (4.407±1.044) % in the first trimester, (4.797±0.621) % in the second trimester and (4.823±0.616) % in the third trimester, and (5.660 ±0.461%) in control group with a P value of 0.00, indicating the highly significant difference between the two groups.
In 2017 Hussein et al. [29] performed a study aimed to compare the platelets indices in pregnant women with and without Gestational DM and to evaluate the relationship between Mean Platelets Volume MPV and Hb A1c. They found that MPV value was significantly higher in GDM group than normal pregnancies. Moreover, there was a positive correlation between MPV and HbA1c values.
In 2017 Abass et al. [30] performed a cross sectional study aimed to correlate the Glycated hemoglobin and red blood cell indices in non-diabetic pregnant women, they concluded that a significant positive correlation between Hb A1c value with Hb, Hct, and MCHC and there was no significant correlation between Hb A1c and other RBCs parameters.
In 2017 Siddig et al. [31] performed a study in Sudanese healthy pregnant ladies and found The mean value of HbA1c in normal pregnancy was found to be 4.37% with a range of (2.8%- 5.5 %). There was no correlation between normal FBG, Hb level, daily caloric intake, age, PH. of DM, PH. of GDM, family history of DM and the level of Hb A1c. According to this study the mean value of Hb A1c in Sudanese healthy pregnant women is 4.37 found within the normal Sudanese values of HbA1c. HbA1c is lower in the third trimester compared to first trimester.
In pregnancy the pregnant mother undergoes significant anatomical and physiological changes in order to nurture and accommodate the developing foetus and prepare the mother for labor and be ready delivery [32]. In a normal pregnancy, between 6 to 10 weeks, there is a decrease in the fasting blood glucose and this continues throughout pregnancy [33]. For the previous 30 years, investigators have attempted to determine whether the glycated hemoglobin A1c (Hb A1c) level during pregnancy may be used as a screening or diagnostic test for gestational diabetes (GDM) [34-35].
One of the studies says the pregnant women had a low Hb A1c, particularly in the first trimester of pregnancy. This might implicate that for prevention of congenital malformations and macrosomia in diabetic pregnant women and HbA1C should be below 5% in the first trimester of pregnancy and below 6% in the third trimester [36-39].
The more recent studies have indicated that the Hb A1c level during pregnancy may predict GDM in women at high risk for diabetes. The New Zealand Ministry of Health recommends that an Hb A1c test be offered to all pregnant women at booking as part of the first antenatal blood screen to detect GDM [40]. The results provided supporting evidence for recent reports that recommended measured the Hb A1c level at early pregnancy as one of blood screening base line tests, and follow the level especially in high risk women.
References
- Roth M (1990) Glycated hemoglobin not glycosylated or glucosylated. Clinical Chemistry 36(6): 1254-1255.
- Telen MJ, Kaufman RE, Foerster J, Rodgers G (2004) The mature erythrocyte. In: Wintrobe’s (Eds.), In: (11th edn). Lippincot: Williams and Wilkins, Philadelphia, USA, p. 230.
- American Diabetes Association (2007) Standards of medical care in diabetes. Diabetes Care 30(suppl 1): S4-S41.
- Huisman TH, Martis EA, Dozy A (1958) Chromatography of hemoglobin types on carboxymethylcellulose. J Lab Clin Med 52(2): 312-327.
- Rahbar S (1968) An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta 22(2): 296-298.
- Rahbar, Blumenfeld O, Ranney HM (1969) Studies of an unusual haemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 36(5): 838-843.
- Trivelli LA, Ranney HM, Lai HT (1971) Hemoglobin components in patients with diabetes mellitus. New Engl J Med 284(7): 353-357.
- Bunn HF, Haney DN, Gabbay KH, Gallop PM (1975) Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun 67(1): 103-109.
- Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, et al. (1976) Corelation of glucose regulation and haemoglobin A1c in diabetes mellitus. Eng J Med 295(8): 417-420.
- Massi-Benedetti M (2006) Changing targets in treatment of type 2 diabetes. Curr Med Res Opin 22 (suppl 2): S5-S13.
- Faerch K, Borch-Johnsen K, Vaag A, Jorgensen T, Witte DR, et al. (2010) Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter 99 study. Diabetologia 53(5): 858-865.
- Gulliford MC, Ukoumunne OC (2001) Determinants of glycated haemoglobin in the general population: associations with diet, alcohol and cigarette smoking. Eur J Clin Nutr 55(7): 615-623.
- Kilpatrick ES, Dominiczak MH, Small M (1996) The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetes. Q J Med 89: 307-312
- Modan M, Meytes D, Rozeman P, Yosef SB, Sehayek E, et al. (1988) Significance of high Hb A1c levels in normal glucose tolerance. Diabetes Care 11(5): 422-428.
- Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L, et al. (1989) Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia 32(12): 864-869.
- Ali IA, Abdalarhim HM, Musa OA (2016) Reference values for hemoglobin A1c in males living in Khartoum state pilot study. Sudan Med Monit 11(3): 91-96.
- Fadul FA, Abdelrhim HM, Ali IA, Musa OA (2017) Normal Values of Hemoglobin A1c among Women in Khartoum State: (A Pilot Study, 2016). International Journal of Science and Research 6(9): 352-357.
- Suhonem L, Hiilesma V, Teramo K (2000) Glycemic control during early pregnancy and fetal malformations in women with type 1 diabetes mellitus. Diabetologia 43(1): 79-82.
- Platt MJ, Stanisstreet M, Casson IF, Howard CV, Walkinshaw S, et al. (2002) St Vincent’s declaration 10 years on: outcomes of diabetic pregnancies. Diabet Med 19(3): 216-220.
- The Diabetes Control and Complications Trial Research Group (1996) Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol 174(4): 1343-1353.
- Ray JG, O’Brien TE, Chan WS (2001) Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM 94: 435-444.
- Willhoite MB, Bennert HW, Palomaky GE, Zaremba MM, Herman WH, et al. (1993) The impact of preconception counselling on pregnancy outcomes. The experience of the Maine diabetes in pregnancy program. Diabetes Care 16: 450-455.
- Nielsen LR, Ekbom P, Damm P, Glümer CH, Merete M, et al. (2004) HbA1c Levels are significantly lower in early and late Pregnancy. Diabetes Care 27(5): 1200-1201.
- Mosca A, Paleari R, Dalfra MG, Cianni DG, Cuccuru I, et al. (2006) Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clinical Chemistry 52(6): 1138-1143.
- O’Connor C, O’Shea PM, Owens LA, Carmody L, Avalos G, et al. (2012) Trimester-specific reference intervals for haemoglobin A1c (HbA1c) in pregnancy. Clin Chem Lab Med 50(5): 905-909.
- O’Kane MJ, Lynch PLM, Moles KW, Magee SE (2001) Determination of diabetes control and complications trial-aligned HbA1c reference range in pregnancy. Clin Chim Acta 311:157-159.
- Shobha P, Mathen S, Abraham J (2016) Glycosylated hemoglobin values in nondiabetic pregnant women in the third trimester and adverse fetal outcomes: An observational study. J Family Med Prim Care 5(3): 646- 651.
- Ismail MIMO, Elmugadam AA (2011) Assessment of Hb A1c in Healthy Pregnant Sudanese Women. Msc Dissertation, University of Science and Technology, college of Medical Laboratory Science, Khartoum, Sudan.
- Hussein EA, Mohamed HA, Elhassan HM, Elamin RA, Saadia M, et al. (2017) Platelets Indices and Glycated hemoglobin (Hb A1c) in Gestational Diabetes Mellitus. Scholars Journal of Applied Medical Sciences (SJAMS) Sch J App Med Sci 5(6A): 2090-2096.
- Awad-Elkareem A, Musa IR, Rayis DA, Adam I, Gasim GI, et al. (2017) Glycated hemoglobin and red blood cell indices in non-diabetic pregnant women. Clin Pract 7(4): 999.
- Siddig AA, Khalid AR, Ali IA, Musa OA (2018) Normal Values of Hemoglobin A1c in Sudanese healthy pregnant ladies in Khartoum state 2017: A pilot Study. Saudi J Med 3(2): 40-45.
- Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A (2016) Physiological changes in pregnancy. Cardiovascular Journal Of Africa 27(2): 89-94.
- Butte NF (2000) Carbohydrate and lipid metabolism in pregnancy: Normal compared with gestational diabetes mellitus. Am J Clin Nutr 71(5 suppl): 1256-1261.
- McFarland KF, Murtiashaw M, Baynes JW (1984) Clinical value of glycosylated serum protein and glycosylated hemoglobin levels in the diagnosis of gestational diabetes mellitus. Obstet Gynecol J 64(4): 516- 518.
- Artal R, Mosley GM, Dorey FJ (1984) Glycohemoglobin as a screening test for gestational diabetes. Am J Obstet and Gynecol 148(4): 412-144.
- Rosemary T, Aldridge V, Richard G, Philip H, Michael S, et al. (2002) Katharine Stanley. Association between outcome of pregnancy and glycemic control in early pregnancy in type 1 diabetes: population based study. British Medical Journal 325(7375): 1275-1276.
- Weykamp C (2013) HbA1c: A Review of Analytical and Clinical Aspects. Ann Lab Med 33(6): 393-400.
- Radder JK, Roosmalen VJ (2005) HbA1c in healthy pregnant women. Neth J Med 63(7): 256-259.
- Yi-Ran H, Panchalli W, Mei-Chun L, Shih-Ting T, Chun-Pai Y, et al. (2017) Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women. Plos One J 12(5): e0177563.
- Hughes RCE, Williman J, Gullam JE (2016) Universal HbA1c Measurement in Early Pregnancy to Detect Type2 Diabetes Reduces Ethnic Disparities in Antenatal Diabetes Screening: A Population- Based Observational Study. Plos One J 11(6): 1-10.